Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 75 of 464 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/27/20
End: 10/23/20
Due: 10/23/21
Phase: N/A
Priority: Normal
Start: 01/15/21
End: 09/15/36
Due: 09/15/37
Personalized Multi-peptide Vaccination in Combination With the TLR1/2 Ligand XS15 in Cancer Patients
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/31/11
End: 10/31/18
Due: 10/31/19
Phase: N/A
Priority: Normal
Start: 10/31/15
End: 11/30/16
Due: 11/30/17
Phase: N/A
Priority: Normal
Start: 07/03/18
End: 01/07/19
Due: 01/07/20
Phase: N/A
Priority: Normal
Start: 06/15/18
End: 04/16/24
Due: 04/16/25
Phase: N/A
Priority: Normal
Start: 09/01/23
End: 08/31/25
Due: 08/31/26
Phase: N/A
Priority: Normal
Start: 07/19/24
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 05/31/05
End: 05/31/07
Due: 05/31/08
Phase: N/A
Priority: Normal
Start: 11/30/16
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 07/19/24
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 06/30/21
End: 04/30/23
Due: 04/30/24
Phase: N/A
Priority: Normal
Start: 11/06/14
End: 02/08/17
Due: 02/08/18
Phase: N/A
Priority: Normal
Start: 07/28/20
End: 03/01/24
Due: 03/01/25
Phase: N/A
Priority: Normal
Start: 05/31/16
End: 11/10/17
Due: 11/10/18
Phase: N/A
Priority: Normal
Start: 01/23/24
End: 01/31/26
Due: 01/31/27
Phase: N/A
Priority: Normal
Start: 01/31/02
End: 12/31/09
Due: 12/31/10
Phase: N/A
Priority: Normal
Start: 05/31/09
End: 12/31/11
Due: 12/31/12
Phase: N/A
Priority: Normal
Start: 09/01/22
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 07/31/15
End: 08/31/19
Due: 08/31/20
Phase: N/A
Priority: Normal
Start: 01/31/12
End: 05/31/14
Due: 05/31/15
Phase: N/A
Priority: Normal
Start: 12/01/07
End: 06/01/12
Due: 06/01/13
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 07/31/13
Due: 07/31/14
Phase: N/A
Priority: Normal
Start: 03/16/20
End: 05/31/20
Due: 05/31/21